Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.10.2023 | Case report

Dabrafenib/nivolumab/trametinib

Vogt-Koyanagi-Harada-like uveitis: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Madoe A, et al. VOGT-KOYANAGI-HARADA DISEASE-LIKE UVEITIS IN A PATIENT WITH ADVANCED MELANOMA TREATED BY SEQUENTIAL ADMINISTRATION OF NIVOLUMAB AND DABRAFENIB/TRAMETINIB THERAPY. Retinal Cases and Brief Reports 17 : 611-615, No. 5, Sep 2023. Available from: URL: http://doi.org/10.1097/ICB.0000000000001251 [Summarised from an abstract] Madoe A, et al. VOGT-KOYANAGI-HARADA DISEASE-LIKE UVEITIS IN A PATIENT WITH ADVANCED MELANOMA TREATED BY SEQUENTIAL ADMINISTRATION OF NIVOLUMAB AND DABRAFENIB/TRAMETINIB THERAPY. Retinal Cases and Brief Reports 17 : 611-615, No. 5, Sep 2023. Available from: URL: http://​doi.​org/​10.​1097/​ICB.​0000000000001251​ [Summarised from an abstract]
Metadaten
Titel
Dabrafenib/nivolumab/trametinib
Vogt-Koyanagi-Harada-like uveitis: case report
Publikationsdatum
01.10.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-47193-3

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Guselkumab

Case report

Methotrexate

Case report

Multiple drugs